obinutuzumab
GAZYVA is classified as formulary status, RESTRICTED to OUTPATIENT ONCOLOGY use.
Reviewed: April 22, 2014
GAZYVA is classified as formulary status, RESTRICTED to OUTPATIENT ONCOLOGY use.
Reviewed: April 22, 2014